- $35.46m
- $14.60m
- $4.01m
Annual balance sheet for CervoMed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 37.3 | 22.5 | 7.79 | 38.9 | 20.9 |
| Net Total Receivables | — | — | 0.915 | 2.25 | 0.427 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 37.8 | 22.6 | 9.96 | 43.1 | 22.9 |
| Net Property, Plant And Equipment | 0 | — | — | — | — |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 37.8 | 22.6 | 9.97 | 43.1 | 22.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 2.93 | 2.42 | 2.6 | 3.88 | 4.66 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.93 | 2.42 | 2.6 | 3.88 | 4.66 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 34.9 | 20.2 | 7.38 | 39.2 | 18.2 |
| Total Liabilities & Shareholders' Equity | 37.8 | 22.6 | 9.97 | 43.1 | 22.9 |
| Total Common Shares Outstanding |